About

Welcome to the Division of Infectious Diseases!

Our 97 faculty, 9 physician fellows, and 107 staff members make the Pitt Division of Infectious Diseases a leader in advancing the science and practice of infectious diseases and in providing infectious disease services to the many communities in the country that lack ID specialist care. Our division provides state-of-the-art care that is easily accessible to patients; conducts cutting-edge research on clinically relevant areas of infectious diseases; trains the next generation of infectious disease physicians and scientists; and, implements programs to protect the public health from epidemic infections.

Our inpatient infectious disease consult teams round at UPMC Presbyterian and Montefiore University Hospitals, the Hillman Cancer Center, UPMC Mercy Hospital, Magee-Women’s Hospital, Western Psychiatric Institute and Clinic, and the VA Pittsburgh Health System. Outpatients are seen in our state-of-the art Center for Care of Infectious Diseases (CCID) located on the top floor (7th) of the Falk Medical Building, and at the UPMC Mercy Center. Our clinical services include general ID, surgical ID, transplant ID, endovascular infections, outpatient parenteral antibiotic therapy, HIV/AIDS Care, HIV/STI Prevention, and Travel Health. By expanding Tele-ID services through our partner ID Connect, we are providing consultations at 49 hospitals in 19 states.

Through cutting-edge research, our faculty is improving the standard of care for treatment and prevention of infectious diseases. Research activities span basic, translational, clinical, and epidemiologic research. Major research foci of the ID Division are HIV-AIDS, antimicrobial resistance, fungal infections, genomic epidemiology, and antibody therapeutics. Total research funding from NIH, CDC, foundations, and industry exceed $20 million annually. Our many research programs offer patients the opportunity to participate in research studies, which improve how we prevent, diagnose, monitor, and treat infectious diseases.

Our Centers of Excellence in Research offer a highly interactive array of research led by world-class investigators.

The Center for AIDS Elimination (CAE) provides clinical, educational, and scientific research support for the purposes of prevention, treatment, and cure of HIV/AIDS. Through the combined efforts of innovative laboratory methods, cutting-edge translational research, patient care, and public health, the CAE is diligently working toward the goal of finding better HIV prevention and treatment, a functional cure for HIV, and ending the AIDS epidemic. The latter goal is being realized locally through participation in the regional “AIDS-free Pittsburgh” initiative involving multidisciplinary stakeholders throughout the Pittsburgh community. The Division is also involved in several NIH-funded network studies including the ACTG, HVTN, and MWCCS, and is part of the Rustbelt CFAR.

The Center for Antibody Therapeutics (CAT) identifies and characterizes novel human monoclonal antibodies as candidate therapeutics and develops novel strategies to increase their safety and efficacy against viruses, cancer, other diseases, and aging.

The Center for Innovative Antimicrobial Therapy (CIAT) investigates and identifies antimicrobial resistance of clinical concern among gram-negative and gram-positive bacterial pathogens. The Center’s areas of research include the genetic and molecular basis of emerging antimicrobial resistance mechanisms; the rapid diagnosis of resistance utilizing phenotypic, genetic, and lipidomic approaches; and, inhibitor-based drug discovery.

The Center for Genomic Epidemiology (CGE) applies innovative microbial genomic and data mining and machine-learning tools to study the epidemiology and evolution of serious pathogens. Examples include research on pathogen transmission; strain emergence; and, methods for detection, investigation, and interruption of outbreaks in healthcare and in the community.

The Center for Healthcare Mycology and Fungal Genomics (CHMFG) focuses on the increasing threat of fungal infections, particularly in immunocompromised individuals. CHM centers on the immunopathology of fungal disease and human disease susceptibility in order to augment the advances being made in fungal diagnostics and drug development.

We are developing knowledgeable and respected researchers, clinicians, and educators through mentoring in our Infectious Diseases Fellowship Training Programs in general ID, transplant ID, and CCM-ID. Our Fellowship Program openings are filled each year with top-ranked applicants. Medical students and residents also receive rigorous clinical and research training in Infectious Diseases. Division faculty provide exceptional educational opportunities for graduate students, medical students, medical residents, and postdoctoral PhD and MD fellows.

Thank you for taking the time to visit our website. We welcome any inquiries you might have about our Division. As we say here, Pitt ID is the place to be!